---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-073776"
form_type: "8-K"
ticker: "NNDM"
cik: "0001643303"
company_name: "Nano Dimension Ltd."
filed_at: "2026-06-15T11:48:12+00:00"
generated_at: "2026-06-15T11:50:14.023063+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nano Dimension signs non-binding term sheet to acquire Infinite Epigenetics for $890M stock consideration

## Summary
- Infinite valued at $890M; Nano valuation based on net cash plus 20% premium plus ~$20M for Essemtec.
- Post-closing, Infinite shareholders to own majority; if >55%, they designate 5 of 7 board seats.
- Nano will spin off legacy assets via CVR to pre-closing Nano shareholders.
- Term sheet includes 30-day exclusivity; no definitive agreement yet.
- Nano to reimburse Infinite up to $3M expenses if definitive deal not signed by EGM date.

## SEC filing metadata
- accession: 0001104659-26-073776
- form_type: 8-K
- ticker: NNDM
- cik: 0001643303
- company_name: Nano Dimension Ltd.
- filed_at: 2026-06-15T11:48:12+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1643303/000110465926073776/0001104659-26-073776-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1643303/000110465926073776/tm2617934d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-073776
- JSON: https://secwatch.observer/filing/0001104659-26-073776.json
- Plain text: https://secwatch.observer/filing/0001104659-26-073776.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.